Entry Point Capital, LLC Teva Pharmaceutical Industries LTD Transaction History
Entry Point Capital, LLC
- $112 Billion
- Q1 2024
A detailed history of Entry Point Capital, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Entry Point Capital, LLC holds 2,102 shares of TEVA stock, worth $34,683. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,102Holding current value
$34,683% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding TEVA
# of Institutions
554Shares Held
548MCall Options Held
19.8MPut Options Held
14M-
Black Rock Inc. New York, NY43.7MShares$721 Million0.01% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E938.6MShares$637 Million36.28% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L334.6MShares$571 Million7.05% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.29.9MShares$493 Million6.74% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L328.8MShares$475 Million4.57% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.3B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...